Exploring how Kenyan women adhere to STI and HIV prevention methods

Understanding STI and HIV prevention adherence among Kenyan women

NIH-funded research Hennepin Healthcare Research Institute · NIH-10875659

This study is looking at what helps or hinders Kenyan women from sticking to STI and HIV prevention methods, like using a medication called doxycycline, to make sure they have better options for staying healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionHennepin Healthcare Research Institute NIH-funded
Lab location1 site (Minneapolis, United States)
Project IDNIH-10875659 on NIH RePORTER

What this research studies

This research focuses on understanding the factors that influence adherence to STI and HIV prevention strategies among Kenyan women. It involves training a physician-scientist to conduct trials and analyze data related to sexual health behaviors and the use of post-exposure prophylaxis (PEP) with doxycycline. The study aims to identify barriers and facilitators to adherence, particularly in the context of gender dynamics and social influences. By leveraging ongoing trials, this research seeks to improve STI prevention methods tailored for women in low-resource settings.

Who could benefit from this research

Good fit: Ideal candidates for this research are Kenyan women at risk of STIs and HIV, particularly those who may benefit from innovative prevention strategies like doxycycline PEP.

Not a fit: Patients who are not at risk for STIs or HIV, or those who do not reside in Kenya, may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved STI and HIV prevention strategies specifically designed for Kenyan women, ultimately reducing infection rates and associated health complications.

How similar studies have performed: Previous research has shown promise in STI prevention strategies among men, but this approach focusing on women is relatively novel and untested.

Where this research is happening

Minneapolis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.